Alkermes Plc (NQ: ALKS )
Price and Volume
Detailed QuoteVolume | 0 |
Open | 27.53 |
Bid (Size) | 26.50 (2) |
Ask (Size) | 43.77 (1) |
Prev. Close | 27.53 |
Today's Range | 27.53 - 27.53 |
52wk Range | 22.01 - 33.71 |
Shares Outstanding | 166,121,384 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Exploring NASDAQ:ALKS's growth characteristics.
February 28, 2024
Beam Therapeutics Stock Jumps To Higher RS Level On Earnings Beat
February 27, 2024
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
February 23, 2024
Earnings Scheduled For February 15, 2024
February 15, 2024
Alkermes's Earnings Outlook
February 14, 2024
Is NASDAQ:ALKS suited for growth investing?
February 07, 2024
NASDAQ:ALKS, an undervalued stock with good fundamentals.
January 19, 2024
Alkermes Stock Gets RS Rating Upgrade; Profits Surge
February 15, 2024
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+
February 13, 2024
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Madrigal Pharmaceuticals Stock Shows Rising Relative Strength
February 06, 2024
NASDAQ:ALKS, a growth stock which is not overvalued.
January 10, 2024
Decoding 5 Analyst Evaluations For Alkermes
January 02, 2024
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
February 02, 2024
3 Top Pharma Stocks to Buy Now: February 2024
February 01, 2024
Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating
January 23, 2024
Cassava Sciences Stock Continues Showing Rising Relative Strength
January 16, 2024
The 3 Most Undervalued Biotech Stocks to Buy in January
January 15, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.